Mostrando 1 - 2 resultados de 2 para a busca 'Michael D. Cameron', tempo de busca: 0.02s Refinar Resultados
  1. 1
    SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats

    SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats por Kevin M. Braunscheidel, Kevin M. Braunscheidel, George Voren, George Voren, Christie D. Fowler, Qun Lu, Alexander Kuryatov, Michael D. Cameron, Ines Ibañez-Tallon, Jon M. Lindstrom, Theodore M. Kamenecka, Paul J. Kenny, Paul J. Kenny

    Publicado em 2024-09-01
    Obter o texto integral
    Artigo
  2. 2
    Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation.

    Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation. por Jing Zhao, Lei Zhang, Xiaodong Mu, Christelle Doebelin, William Nguyen, Callen Wallace, Daniel P Reay, Sara J McGowan, Lana Corbo, Paula R Clemens, Gabriela Mustata Wilson, Simon C Watkins, Laura A Solt, Michael D Cameron, Johnny Huard, Laura J Niedernhofer, Theodore M Kamenecka, Paul D Robbins

    Publicado em 2018-06-01
    Obter o texto integral
    Artigo

Ferramentas de busca: